Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies

  • Massimo De Paschale | massimo.depaschale@ao-legnano.it
  • Luisa Belvisi
  • Debora Cagnin
  • Teresa Cerulli
  • Maria Teresa Manco
  • Laura Marinoni
  • Alessia Paganini
  • Pierangelo Clerici

Abstract

We evaluated the correlation among four commercial ELISA tests for the presence of anti-Mycoplasma pneumoniae IgM antibodies in 36 samples obtained from patients with respiratory infections.The overall concordance among the four tests was 30%, while the one among single tests varies from 39% to 75%. Given the variability of the results, it is necessary to implement a External Quality Control specific for anti-Mycoplasma pneumoniae IgM antibodies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2008-06-30
Info
Issue
Section
Short Communications
Keywords:
External quality control, IgM anti-Mycoplasma
Statistics
  • Abstract views: 482

  • PDF: 547
How to Cite
De Paschale, M., Belvisi, L., Cagnin, D., Cerulli, T., Manco, M. T., Marinoni, L., Paganini, A., & Clerici, P. (2008). Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies. Microbiologia Medica, 23(2). https://doi.org/10.4081/mm.2008.2584

Most read articles by the same author(s)